Indigo Carmine (American Regent, Inc.)


Welcome to the PulseAid listing for the Indigo Carmine drug offered from American Regent, Inc.. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: American Regent, Inc.
NON-PROPRIETARY NAME: Indigo Carmine
SUBSTANCE NAME: INDIGOTINDISULFONATE SODIUM
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS:
ROUTE: INTRAMUSCULAR; INTRAVENOUS
DOSAGE FORM: INJECTION, SOLUTION
MARKETING CATEGORY NAME: UNAPPROVED DRUG OTHER
START MARKETING DATE: 1990-09-30
END MARKETING DATE: 0000-00-00


Indigo Carmine HUMAN PRESCRIPTION DRUG Details:

Item DescriptionIndigo Carmine from American Regent, Inc.
LABELER NAME: American Regent, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 8(mg/mL)
START MARKETING DATE: 1990-09-30
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0517-0375_9b1f07e8-9cc5-4c8e-9a9c-d6f4670dbf42
PRODUCT NDC: 0517-0375
APPLICATION NUMBER:

Other INDIGOTINDISULFONATE SODIUM Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
American Regent, Inc.Indigo Carmine